Automotive companies are increasingly using lightweight materials to improve vehicle fuel economy. However, incorporating those materials into new vehicles is time-consuming and costly. NIST data and models are helping automakers understand and predict how materials behave in the harsh conditions inherent to manufacturing.
Protein-based biologic drugs, which are increasingly used to treat cancers, autoimmune disorders and infectious diseases, are hard to produce, store and deliver reliably. Better measurement tools developed by NIST drive innovation and lower costs associated with these drugs.
In the past decade, hundreds of thousands of patients were affected by two major recalls of electrical leads used in cardiac pacemakers and implanted defibrillators due to early failures. Today, NIST’s reliability tests are helping manufacturers ensure their cardiac devices last for the length of time promised to patients.
Athletes, warfighters and even children riding their bikes all can benefit from better protective gear to prevent head injuries. The Head Health Challenge launched by the NFL, Under Armour, GE and NIST is inspiring new advanced materials that could provide solutions to this problem.
As much as 35 percent of vaccines shipped worldwide is wasted because it is transported or stored at temperatures too high or too low. NIST’s research is helping the Centers for Disease Control and Prevention recommend effective ways for vaccine providers to protect their vaccines and reduce waste.